1834 INVESTMENT ADVISORS CO - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 166 filers reported holding ANI PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 6.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
1834 INVESTMENT ADVISORS CO ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$010.0%0.00%
Q3 2020$010.0%0.00%
Q2 2020$010.0%0.00%
Q1 2020$010.0%0.00%
Q4 2019$010.0%0.00%
Q3 2019$010.0%0.00%
Q2 2019$010.0%0.00%
Q1 2019$010.0%0.00%
Q4 2018$010.0%0.00%
Q3 2018$010.0%0.00%
Q2 2018$01
-50.0%
0.00%
Q1 2018$020.0%0.00%
Q4 2017$020.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 327,929$9,218,0003.24%
Parkman Healthcare Partners LLC 107,911$3,033,0000.89%
Global Alpha Capital Management Ltd. 350,231$9,845,0000.85%
MARATHON CAPITAL MANAGEMENT 75,010$2,109,0000.60%
TANG CAPITAL MANAGEMENT LLC 100,000$2,811,0000.56%
EMERALD ADVISERS, LLC 354,045$9,952,0000.38%
EMERALD MUTUAL FUND ADVISERS TRUST 299,493$8,419,0000.37%
Sio Capital Management, LLC 40,000$1,124,0000.37%
Stonepine Capital Management, LLC 26,060$733,0000.30%
Mitsubishi UFJ Asset Management (UK) Ltd. 23,000$646,530,0000.29%
View complete list of ANI PHARMACEUTICALS INC shareholders